Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Boston, MA.
The company received a thumbs-down from the FDA for its lead pipeline candidate.
The company announced the pricing of a public offering of common stock.
SPPI earnings call for the period ending June 30, 2022.
SPPI earnings call for the period ending March 31, 2022.
SPPI earnings call for the period ending December 31, 2021.
SPPI earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.